Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma G Held, N Murawski, M Ziepert, J Fleckenstein, V Pöschel, C Zwick, ... Journal of Clinical Oncology 32 (11), 1112-1118, 2014 | 256 | 2014 |
Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study CM Werner, A Hecksteden, A Morsch, J Zundler, M Wegmann, J Kratzsch, ... European heart journal 40 (1), 34-46, 2019 | 201 | 2019 |
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic … C Buske, E Hoster, M Dreyling, H Eimermacher, H Wandt, B Metzner, ... Leukemia 23 (1), 153-161, 2009 | 195 | 2009 |
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab JT Bittenbring, F Neumann, B Altmann, M Achenbach, J Reichrath, ... J Clin Oncol 32 (29), 3242-3248, 2014 | 167 | 2014 |
Vitamin D–dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma H Bruns, M Büttner, M Fabri, D Mougiakakos, JT Bittenbring, ... Science translational medicine 7 (282), 282ra47-282ra47, 2015 | 94 | 2015 |
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial I Krämer, S Stilgenbauer, S Dietrich, S Böttcher, M Zeis, M Stadler, ... Blood, The Journal of the American Society of Hematology 130 (12), 1477-1480, 2017 | 81 | 2017 |
The impact of Fc-γ receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab M Ahlgrimm, M Pfreundschuh, M Kreuz, E Regitz, KD Preuss, ... Blood, The Journal of the American Society of Hematology 118 (17), 4657-4662, 2011 | 80 | 2011 |
Vitamin D deficiency in head and neck cancer patients–prevalence, prognostic value and impact on immune function F Bochen, B Balensiefer, S Körner, JT Bittenbring, F Neumann, A Koch, ... Oncoimmunology 7 (9), e1476817, 2018 | 66 | 2018 |
IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination L Thurner, C Kessel, N Fadle, E Regitz, F Seidel, I Kindermann, S Lohse, ... New England Journal of Medicine 387 (16), 1524-1527, 2022 | 55 | 2022 |
Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with intermediate-or high-risk acute myeloid leukemia in … F Malard, M Labopin, G Stuhler, J Bittenbring, A Ganser, J Tischer, ... Biology of Blood and Marrow Transplantation 23 (2), 278-284, 2017 | 50 | 2017 |
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European … F Onida, LC de Wreede, A van Biezen, DJ Eikema, JL Byrne, AP Iori, ... British journal of haematology 177 (5), 759-765, 2017 | 46 | 2017 |
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the … E González-Barca, A Boumendil, D Blaise, M Trněný, T Masszi, H Finel, ... Bone marrow transplantation 55 (2), 393-399, 2020 | 43 | 2020 |
Integrated meta-omic analyses of the gastrointestinal tract microbiome in patients undergoing allogeneic hematopoietic stem cell transplantation A Kaysen, A Heintz-Buschart, EEL Muller, S Narayanasamy, L Wampach, ... Translational Research 186, 79-94. e1, 2017 | 38 | 2017 |
Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway L Busch, D Mougiakakos, M Büttner-Herold, MJ Müller, DA Volmer, ... Leukemia 32 (11), 2445-2458, 2018 | 35 | 2018 |
MDM2 gene SNP309 T/G and p53gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians J Bittenbring, F Parisot, A Wabo, M Mueller, L Kerschenmeyer, M Kreuz, ... BMC cancer 8, 1-10, 2008 | 35 | 2008 |
Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita M Kirschner, A Maurer, MW Wlodarski, MS Ventura Ferreira, AS Bouillon, ... Leukemia 32 (8), 1762-1767, 2018 | 33 | 2018 |
Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A KD Preuss, M Pfreundschuh, N Fadle, E Regitz, S Raudies, N Murwaski, ... Blood, The Journal of the American Society of Hematology 118 (12), 3340-3346, 2011 | 29 | 2011 |
Cost‑effectiveness of precision cancer medicine‑current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical … K Christofyllakis, JT Bittenbring, L Thurner, M Ahlgrimm, S Stilgenbauer, ... Molecular and Clinical Oncology 16 (1), 1-4, 2022 | 28 | 2022 |
Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study G Assmann, J Voswinkel, M Mueller, J Bittenbring, J Koenig, A Menzel, ... Clin Exp Rheumatol 27 (4), 615-619, 2009 | 22 | 2009 |
Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis V Sheth, M Labopin, J Canaani, L Volin, A Brecht, A Ganser, J Mayer, ... Bone marrow transplantation 54 (4), 531-539, 2019 | 21 | 2019 |